http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100851802-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
filingDate | 2004-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-08-13^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-08-13^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100851802-B1 |
titleOfInvention | 2,3-dihydro-6-nitroimidazo [2,1-k] oxazole compound for the treatment of tuberculosis |
abstract | The present invention provides 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds represented by the formula:n n n n n n n n In formula, R < 1> represents a hydrogen atom or a C1-C6 alkyl group,n n n n represents an integer of 0 to 6,n n n R 1 and — (CH 2 ) n R 2 together with the carbon atoms adjacent thereto may form a spiro ring represented by the following formula (30),n n n R 2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group, or the like;n n n n n n n n In the formula, RRR represents a piperidyl group which may have a substituent on the piperidine ring.n n n The compounds of the present invention have an excellent bactericidal action against Mycobacterium tuberculosis, Multidrug-resistant Mycobacterium tuberculosis and Atypical anti-acidic bacteria. |
priorityDate | 2003-10-31^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 787 of 787.